INSIGHTS ON DRUG DEVELOPMENT

• Overcoming Challenges In Ophthalmic Formulations

  Discover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.

• How Organ-Chips Are Transforming Women's Reproductive Health Research

  Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

• Molecular Properties Of PROTACs And The Relationship To Formulation Design

  Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

• Five Practical Considerations To Move From Concept To Clinic

  Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.

• From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development

  3/8/2026

  See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.

• Navigating Emerging Therapeutics: Cannabinoid And Psilocybin Drug Development

  1/15/2026

  Cannabinoid and psilocybin therapies are advancing rapidly, and Mikart supports innovators with DEA-licensed facilities, formulation expertise, regulatory guidance, and manufacturing capabilities from clinical development to commercialization.

• How Patent Expirations Will Reshape The Dry Powder Inhaler (PDI) Market

  4/10/2026

  Patent expirations on dry powder inhalers are driving rapid market competition. Discover how optimized mechanical dosing speeds scale-up and protects profit margins.

• Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS

  7/29/2025

  Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.

• Navigating Drug Design In 'Beyond The Rule Of 5' Landscape

  6/17/2026

  New drug modalities are transforming treatment but bring new challenges. See how hybrid approaches that combine biologics and chemistry are redefining the design of innovative therapies.